Stay updated on Losmapimod in COVID: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Losmapimod in COVID: Safety & Efficacy Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov site footer now displays revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-22T14:22:31.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The temporary NIH notice about website updates and the shift from “Artificial Intelligence” to “Super Intelligence” is no longer displayed above the error page.
    Difference
    1%
    Check dated 2026-11-08T14:04:13.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The site revision changed from v3.7.2 to v3.8.0 in the footer; the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-11-01T15:22:34.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    A banner announces NIH’s website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T14:19:59.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2 on the ClinicalTrials.gov page.
    Difference
    0.2%
    Check dated 2026-10-18T15:31:20.000Z thumbnail image
  7. Check
    42 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T15:15:24.000Z thumbnail image

Stay in the know with updates to Losmapimod in COVID: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Losmapimod in COVID: Safety & Efficacy Clinical Trial page.